देश: यूनाइटेड किंगडम
भाषा: अंग्रेज़ी
स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ethinylestradiol; Levonorgestrel
Lupin Healthcare (UK) Ltd
G03AA07
Ethinylestradiol; Levonorgestrel
30microgram ; 150microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 07030100; GTIN: 8901107025069
· If a close relative has or has had breast cancer PACKAGE LEAFLET: INFORMATION FOR THE USER BLEEDING BETWEEN PERIODS During the first few months that you are taking Maexeni, you may have unexpected bleeding · If you have a disease of the liver or the gallbladder MAEXENI 150/30 MICROGRAM FILM-COATED TABLETS (bleeding outside the gap week). If this bleeding lasts longer than a few months, or if it begins after · If you have diabetes levonorgestrel / ethinylestradiol some months, talk to your doctor who will investigate the cause. · If you have depression READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS · If you have Crohn's disease or ulcerative colitis (inflammatory bowel disease) WHAT TO DO IF NO BLEEDING OCCURS IN THE GAP WEEK IMPORTANT INFORMATION FOR YOU. · If you have HUS (haemolytic uraemic syndrome; a blood disease that causes kidney damage) If you have taken all the tablets correctly, have not vomited or had severe diarrhoea, and you have · Keep this leaflet. You may need to read it again. not taken any other medicines, it is highly unlikely that you are pregnant. · If you have epilepsy (see “Other medicines and Maexeni”) · If you have any further questions, ask your doctor, pharmacist or family planning nurse. If your period (withdrawal bleeding) does not happen twice in a row, you may be pregnant. · If you have SLE (systemic lupus erythematosus; a disease of the immune system) · This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, Contact your doctor immediately. Do not start the next strip until you are sure that you are not · If you have a disease that first appeared during pregnancy or earlier use of sex hormones (for even if their signs of illness are the same as yours. pregnant. example, hearing loss, porphyria (a disease of the blood), gestational herpes (skin rash with · If you get any side effects, talk to your doctor, pharmacist or family planning nurse. This vesicles during pregnancy), Sydenh पूरा दस्तावेज़ पढ़ें
OBJECT 1 MAEXENI 150/30 MICROGRAM FILM COATED TABLETS Summary of Product Characteristics Updated 08-Jan-2018 | Lupin Healthcare (UK) Ltd 1. Name of the medicinal product Maexeni 150/30 microgram film coated tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol Excipient(s) with known effect: Each tablet contains 58.32 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet. Yellow, round, biconvex, film-coated tablet, debossed with “LE4” on one side and plain on the other side. 4. Clinical particulars 4.1 Therapeutic indications Oral contraception. 4.2 Posology and method of administration How to use Maexeni tablets Tablets must be taken orally in the order directed on the blister package at about the same time every day, with some liquid if necessary. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval, during which time a withdrawal bleed usually occurs. The bleeding usually starts within 2 to 3 days after the last tablet and may not end before the next pack is started. How to start the use of Maexeni tablets • _No preceding hormonal contraceptive use [in the past month]_ Tablet-taking is started on day 1 of the woman's natural cycle (= the first day of her menstrual bleeding). Starting on days 2–5 is allowed but in that case an additional barrier method is recommended for the first 7 days of the first cycle • _Changing from another combined hormonal contraceptive (COC, vaginal ring, transdermal patch)_ The use of Maexeni tablets is preferably started on the day after the last active tablet of the previous COC (or after removal of the ring or patch), but at the latest on the day following the usual tablet-free (ring- free, patch-free) break or the last placebo tablet of the previous hormonal contraceptive. • _Changing from a progestogen-only method (oralpill, injecti पूरा दस्तावेज़ पढ़ें